Wasatch Advisors LP Sells 186,899 Shares of Addus HomeCare Corporation $ADUS

Wasatch Advisors LP trimmed its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 21.5% in the second quarter, HoldingsChannel.com reports. The fund owned 680,926 shares of the company’s stock after selling 186,899 shares during the period. Wasatch Advisors LP’s holdings in Addus HomeCare were worth $68,413,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Leeward Investments LLC MA increased its holdings in Addus HomeCare by 9.4% during the first quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock worth $11,318,000 after buying an additional 10,414 shares during the last quarter. Burney Co. purchased a new position in Addus HomeCare in the fourth quarter valued at about $1,841,000. Vanguard Group Inc. boosted its stake in Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after acquiring an additional 10,501 shares during the last quarter. SG Americas Securities LLC grew its position in shares of Addus HomeCare by 176.0% during the 1st quarter. SG Americas Securities LLC now owns 27,303 shares of the company’s stock valued at $2,557,000 after acquiring an additional 17,411 shares during the period. Finally, Punch & Associates Investment Management Inc. grew its position in shares of Addus HomeCare by 6.0% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 193,890 shares of the company’s stock valued at $18,158,000 after acquiring an additional 10,936 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 788 shares of company stock valued at $73,506 over the last three months. 4.10% of the stock is owned by company insiders.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $116.89 on Wednesday. The firm has a market cap of $2.18 billion, a P/E ratio of 20.51, a price-to-earnings-growth ratio of 1.60 and a beta of 0.87. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The company’s 50 day moving average is $105.21 and its 200-day moving average is $101.81. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The company had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. During the same period last year, the firm earned $1.49 EPS. Addus HomeCare’s revenue for the quarter was up 8.0% on a year-over-year basis. Sell-side analysts predict that Addus HomeCare Corporation will post 6.29 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Barclays lifted their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Royal Bank Of Canada upped their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Finally, Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $130.88.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.